We have never been closer to cracking cancer. MIT Startup Exchange, in collaboration with the MIT Koch Institute, is convening the 2nd annual Cracking Cancer event to discuss the latest advances in cancer innovation from the perspective of industry, academia, venture, and startups in the MIT ecosystem.
James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Lightning Talks featuring startups: Enbiotix, Ginkgo Bioworks, ManusBio, Glympse Bio, BioDevek, Asimov, and BioBuilder.
James Gado - Welcome
Caleb Harper - Academic Innovator
Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
JC Gutiérrez-Ramos, President and CEO, Synlogic